• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆神经丝轻链与简易精神状态检查评分的联合预测可在 5 年内从轻度认知障碍进展为阿尔茨海默病。

Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.

机构信息

ANU Medical School, Australian National University, Canberra, Australia.

Centre for Research on Ageing, Health and Wellbeing, Australian National University, Canberra, Australia.

出版信息

J Alzheimers Dis. 2021;82(3):951-964. doi: 10.3233/JAD-210092.

DOI:10.3233/JAD-210092
PMID:34120902
Abstract

BACKGROUND

Individuals with mild cognitive impairment (MCI) are at high risk of progression to Alzheimer's disease (AD) dementia, but some remain stable. There is a need to identify those at higher risk of progression to improve patient management and outcomes.

OBJECTIVE

To evaluate the trajectory of plasma neurofilament light chain (pNFL) prior to progression from MCI to AD dementia, the performance of pNFL, in combination with the Mini-Mental State Examination (MMSE), as a predictor of progression from MCI to AD dementia and to inform clinicians on the use of pNFL as a predictive biomarker.

METHODS

Participants (n = 440) with MCI and longitudinal follow-up (mean = 4.2 years) from the AD Neuroimaging Initiative dataset were included. pNFL as a marker for neurodegeneration and the MMSE as a cognitive measure were investigated as simple/practical predictors of progression. The risk of progressing from MCI to AD dementia associated with pNFL and MMSE scores was assessed using Cox and logistic regression models.

RESULTS

The current risk of progression to AD dementia was 37%higher in individuals with high pNFL (> 56 ng/L) compared to those with average pNFL (≤40 ng/L). A combination of baseline pNFL and MMSE could differentiate those who progressed within 5 years (AUC = 0.75) from stable individuals. Including change in MMSE over 6-12 months further improved the model (AUC = 0.84).

CONCLUSION

Our findings reveal that combining pNFL with a simple dementia screener (MMSE) can reliably predict whether a person with MCI is likely to progress to AD dementia within 5 years.

摘要

背景

轻度认知障碍(MCI)个体发生阿尔茨海默病(AD)痴呆的风险较高,但也有一些个体保持稳定。因此,需要确定那些进展风险较高的患者,以改善患者的管理和结局。

目的

评估 MCI 进展为 AD 痴呆前血浆神经丝轻链(pNFL)的轨迹,以及 pNFL 与简易精神状态检查(MMSE)相结合作为预测 MCI 进展为 AD 痴呆的指标的性能,并为临床医生提供使用 pNFL 作为预测生物标志物的信息。

方法

纳入来自 AD 神经影像学倡议数据集的 440 名 MCI 患者和纵向随访(平均 4.2 年)。将 pNFL 作为神经退行性变的标志物和 MMSE 作为认知测量,作为进展的简单/实用预测指标进行研究。使用 Cox 和逻辑回归模型评估 pNFL 和 MMSE 评分与从 MCI 进展为 AD 痴呆相关的风险。

结果

与 pNFL 和 MMSE 评分平均值(≤40ng/L)相比,pNFL 较高(>56ng/L)的个体进展为 AD 痴呆的当前风险高 37%。基线 pNFL 和 MMSE 的组合可以区分出在 5 年内进展的个体(AUC=0.75)和稳定的个体。将 6-12 个月内 MMSE 的变化包括在内,进一步改善了模型(AUC=0.84)。

结论

我们的研究结果表明,将 pNFL 与简单的痴呆筛查(MMSE)相结合,可以可靠地预测 MCI 患者是否有可能在 5 年内进展为 AD 痴呆。

相似文献

1
Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.血浆神经丝轻链与简易精神状态检查评分的联合预测可在 5 年内从轻度认知障碍进展为阿尔茨海默病。
J Alzheimers Dis. 2021;82(3):951-964. doi: 10.3233/JAD-210092.
2
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.阿尔茨海默病患者纵向血浆神经丝轻链与神经退行性变的关系。
JAMA Neurol. 2019 Jul 1;76(7):791-799. doi: 10.1001/jamaneurol.2019.0765.
3
Predicting Longitudinal Cognitive Decline and Alzheimer's Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers.基于血浆生物标志物预测轻度认知障碍患者的纵向认知下降和阿尔茨海默病转化。
Cells. 2024 Jun 22;13(13):1085. doi: 10.3390/cells13131085.
4
Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.生物标志物组合对轻度认知障碍向阿尔茨海默病转化的预测价值增加。
Transl Neurodegener. 2020 Aug 3;9(1):30. doi: 10.1186/s40035-020-00210-5.
5
Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.阿尔茨海默病患者血浆神经丝轻链与神经退行性变的关联
JAMA Neurol. 2017 May 1;74(5):557-566. doi: 10.1001/jamaneurol.2016.6117.
6
Utility of Plasma Neurofilament Light in the 1Florida Alzheimer's Disease Research Center (ADRC).血浆神经丝轻链在佛罗里达州阿尔茨海默病研究中心(ADRC)中的应用。
J Alzheimers Dis. 2021;79(1):59-70. doi: 10.3233/JAD-200901.
7
Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's disease.埃尔朗根评分作为预测阿尔茨海默病轻度认知障碍向痴呆进展的工具。
Alzheimers Res Ther. 2019 Jan 5;11(1):2. doi: 10.1186/s13195-018-0456-x.
8
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.生物标志物组合对预测轻度认知障碍向阿尔茨海默病痴呆进展的增量价值。
Alzheimers Res Ther. 2017 Oct 10;9(1):84. doi: 10.1186/s13195-017-0301-7.
9
Potential role of blood pressure variability and plasma neurofilament light in the mechanism of comorbidity between Alzheimer's disease and cerebral small vessel disease.血压变异性和血浆神经丝轻链在阿尔茨海默病和脑小血管病合并症发病机制中的潜在作用。
Alzheimers Dement. 2024 Jul;20(7):4891-4902. doi: 10.1002/alz.14056. Epub 2024 Jun 19.
10
Follow-up Comparisons of Two Plasma Biomarkers of Alzheimer's Disease, Neurofilament Light Chain, and Oligomeric Aβ: A Pilot Study.阿尔茨海默病两种血浆生物标志物(神经丝轻链和寡聚态 Aβ)的随访比较:一项初步研究。
Curr Alzheimer Res. 2023;20(10):715-724. doi: 10.2174/0115672050284054240119101834.

引用本文的文献

1
Association Between Serum Methylmalonic Acid (A Marker of Mitochondrial Dysfunction) and Serum Neurofilament Light Chains in a U.S. Population: a Cross-Sectional Analysis From NHANES 2013-2014.美国人群中血清甲基丙二酸(线粒体功能障碍标志物)与血清神经丝轻链之间的关联:2013 - 2014年美国国家健康与营养检查调查的横断面分析
Brain Behav. 2025 Aug;15(8):e70775. doi: 10.1002/brb3.70775.
2
Ligature-induced periodontitis in a transgenic mouse model of Alzheimer's disease dysregulates neuroinflammation, exacerbates cognitive impairment, and accelerates amyloid pathology.在阿尔茨海默病转基因小鼠模型中,结扎诱导的牙周炎会使神经炎症失调,加剧认知障碍,并加速淀粉样蛋白病变。
Brain Behav Immun Health. 2025 Feb 25;44:100969. doi: 10.1016/j.bbih.2025.100969. eCollection 2025 Mar.
3
Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting study.血浆神经丝轻链作为神经退行性疾病认知下降的预后标志物:一项临床研究。
Alzheimers Res Ther. 2024 Oct 19;16(1):231. doi: 10.1186/s13195-024-01593-7.
4
Plasma Biomarkers of Alzheimer's Disease and Neurodegeneration According to Sociodemographic Characteristics and Chronic Health Conditions.根据社会人口特征和慢性健康状况,阿尔茨海默病和神经退行性变的血浆生物标志物。
J Prev Alzheimers Dis. 2024;11(5):1189-1197. doi: 10.14283/jpad.2024.142.
5
Impact of amyloid and cardiometabolic risk factors on prognostic capacity of plasma neurofilament light chain for neurodegeneration.淀粉样蛋白和心脏代谢危险因素对神经退行性病变患者血浆神经丝轻链的预后能力的影响。
Alzheimers Res Ther. 2024 Sep 12;16(1):202. doi: 10.1186/s13195-024-01564-y.
6
Cluster analysis dissecting cognitive deficits in older adults with major depressive disorder and the association with neurofilament light chain.基于聚类分析探讨伴发认知障碍的老年抑郁症患者的认知缺陷及其与神经丝轻链的相关性。
BMC Geriatr. 2024 Apr 16;24(1):344. doi: 10.1186/s12877-024-04960-z.
7
Blood Biomarkers of Alzheimer's Disease and Cognition: A Literature Review.阿尔茨海默病和认知的血液生物标志物:文献综述。
Biomolecules. 2024 Jan 11;14(1):93. doi: 10.3390/biom14010093.